brexanolone

FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
Xconomy
Tue, 03/19/19 - 08:27 pm
SAGE Therapeutics
postpartum depression
Zulresso
brexanolone
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval
Xconomy
Fri, 11/2/18 - 07:54 pm
FDA
advisory panels
SAGE Therapeutics
postpartum depression
brexanolone
FDA reviewers: REMS could allay safety concerns for Sage's brexanolone
BioCentury
Wed, 10/31/18 - 06:47 pm
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
brexanolone
REMS
Sage Therapeutics wins priority review for intravenous postpartum depression drug
Drug Delivery Business News
Wed, 05/30/18 - 10:08 am
SAGE Therapeutics
FDA
brexanolone
postpartum depression
Sage Postpartum Depression Drug Heads to FDA Review
Xconomy
Mon, 04/23/18 - 09:35 am
SAGE Therapeutics
FDA
brexanolone
postpartum depression
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 11/12/17 - 10:32 am
biotech
Nektar
earnings
SAGE Therapeutics
brexanolone
postpartum depression
Valeant Pharmaceuticals
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug
Xconomy
Thu, 11/9/17 - 10:04 am
SAGE Therapeutics
postpartum depression
brexanolone
FDA
clinical trials
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
Sage’s epilepsy drug fails to do better than placebo in key clinical trial
Stat
Tue, 09/12/17 - 10:01 am
SAGE Therapeutics
epilepsy
clinical trials
brexanolone